Liraglutide

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5810 publications

Adjunctive Treatments for Patients with Type 1 Diabetes Using Automated Insulin Delivery Systems. A Narrative Review.

Adjunctive Treatments for Patients with Type 1 Diabetes Using Automated Insulin Delivery Systems. A Narrative Review.

Journal: Diabetes technology & therapeutics

Published: September 04, 2026

Recent Advances in Glucagon-Like Peptide-1 Receptor and Melanocortin-4 Receptor Agonists for the Treatment of Obesity and Type 2 Diabetes.

Recent Advances in Glucagon-Like Peptide-1 Receptor and Melanocortin-4 Receptor Agonists for the Treatment of Obesity and Type 2 Diabetes.

Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

Published: September 04, 2026

Liraglutide Attenuates Hepatocyte Ferroptosis in an In Vitro Model of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Liraglutide Attenuates Hepatocyte Ferroptosis in an In Vitro Model of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Physiological research

Published: September 04, 2026

Safety and Glycemic Efficacy of Perioperative Liraglutide in Cardiac Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Safety and Glycemic Efficacy of Perioperative Liraglutide in Cardiac Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Journal: Cardiology in review

Published: September 04, 2026

Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes : An Updated Systematic Review.

Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes : An Updated Systematic Review.

Journal: Annals of internal medicine

Published: August 31, 2026

Influence of GLP-1 Receptor Agonists on Surgical and Nonsurgical Treatment of Ankle Osteoarthritis.

Influence of GLP-1 Receptor Agonists on Surgical and Nonsurgical Treatment of Ankle Osteoarthritis.

Journal: Foot & ankle specialist

Published: August 18, 2026

Glucagon-like Peptide-1 Receptor Agonist-Associated Injection Site and Dermatologic Reactions.

Glucagon-like Peptide-1 Receptor Agonist-Associated Injection Site and Dermatologic Reactions.

Journal: Clinics in dermatology

Published: August 14, 2026

Gastrointestinal metabolic surgery improves salt-sensitive hypertension via GLP-1-mediated inhibition of the RAS/NHE3 axis

Gastrointestinal metabolic surgery improves salt-sensitive hypertension via GLP-1-mediated inhibition of the RAS/NHE3 axis

Journal: Zhonghua xin xue guan bing za zhi

Published: August 13, 2026

Glucagon-like peptide-1 receptor agonist-based regimens compared with metformin-based regimens for preventing cardiovascular disease in adults with type 2 diabetes mellitus.

Glucagon-like peptide-1 receptor agonist-based regimens compared with metformin-based regimens for preventing cardiovascular disease in adults with type 2 diabetes mellitus.

Journal: The Cochrane database of systematic reviews

Published: August 10, 2026

Trends in glucagon-like peptide-1 receptor agonist utilization and expenditure in Croatia.

Trends in glucagon-like peptide-1 receptor agonist utilization and expenditure in Croatia.

Journal: The Journal of international medical research

Published: August 08, 2026

A clinical and experimental investigation of liraglutide effects on the brain-kidney axis.

A clinical and experimental investigation of liraglutide effects on the brain-kidney axis.

Journal: Science advances

Published: August 05, 2026

Surgery on Patients Taking Glucagon-Like Peptide-1 Receptor Agonists.

Surgery on Patients Taking Glucagon-Like Peptide-1 Receptor Agonists.

Journal: Advances in surgery

Published: August 05, 2026

Showing 1-12 of 5,810

Last Updated: 09/26/2026